GSK-3β/β-catenin is considered to be an important downstream cascade of AKT in regulating cancer metastasis; thus, we investigated if ZSD inhibited growth and metastasis in lung cancer by modulating AKT/GSK-3β/β-catenin signaling. The gene discussed is AKT1; the disease is lung carcinoma.